INTERLEUKIN INHIBITORS
- anakinra (KINERET)
- basiliximab (SIMULECT)
- bimekizumab (BIMZELX)
- brodalumab (SILIQ)
- canakinumab (ILARIS)
- guselkumab (TREMFYA I.V., TREMFYA ONE-PRESS, TREMFYA)
- ixekizumab (TALTZ)
- mirikizumab (OMVOH, OMVOH)
- risankizumab (SKYRIZI)
- sarilumab (KEVZARA)
- satralizumab (ENSPRYNG)
- secukinumab (COSENTYX)
- siltuximab (SYLVANT)
- spesolimab (SPEVIGO)
- tildrakizumab (ILUMYA)
- tocilizumab (ACTEMRA, AVTOZMA, TYENNE)
- ustekinumab (STEQEYMA IV, FINLIUS I.V., STEQEYMA, OTULFI I.V., YESINTEK I.V., STELARA, FINLIUS, WEZLANA I.V., STELARA I.V., OTULFI, YESINTEK, WEZLANA, JAMTEKI I.V., JAMTEKI)
Using Health Canada Drug Database
updated on 04Jun2026.